The estimated Net Worth of Eric Patzer is at least 885$ dollars as of 24 June 2024. Dr Patzer owns over 714,286 units of Aridis Pharmaceuticals Inc stock worth over 885$ and over the last 4 years he sold ARDS stock worth over 0$.
Dr has made over 3 trades of the Aridis Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 714,286 units of ARDS stock worth 50,000$ on 24 June 2024.
The largest trade he's ever made was buying 714,286 units of Aridis Pharmaceuticals Inc stock on 24 June 2024 worth over 50,000$. On average, Dr trades about 146,292 units every 213 days since 2020. As of 24 June 2024 he still owns at least 884,600 units of Aridis Pharmaceuticals Inc stock.
You can see the complete history of Dr Patzer stock trades at the bottom of the page.
Dr. Eric J. Patzer is the Exec. Chairman at Aridis Pharmaceuticals Inc.
Dr Patzer is 71, he's been the Exec. Chairman of Aridis Pharmaceuticals Inc since . There are no older and 5 younger executives at Aridis Pharmaceuticals Inc.
Eric's mailing address filed with the SEC is C/O ARIDIS PHARMACEUTICALS, INC., 983 UNIVERSITY AVE, BLDG. B, LOS GATOS,, CA, 95032.
Over the last 6 years, insiders at Aridis Pharmaceuticals Inc have traded over 0$ worth of Aridis Pharmaceuticals Inc stock and bought 1,445,847 units worth 181,502$ . The most active insiders traders include Vu Truong、Eric Patzer、Fred Kurland. On average, Aridis Pharmaceuticals Inc executives and independent directors trade stock every 89 days with the average trade being worth of 125$. The most recent stock trade was executed by Eric Patzer on 24 June 2024, trading 714,286 units of ARDS stock currently worth 50,000$.
aridis is a privately held infectious diseases focused company in san jose, ca, usa. aridis’ advanced formulation and delivery technologies are combined with proprietary products portfolio to create potent drug candidates that are packaged into convenient to administer, "ready-to-use" formats.
Aridis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: